HPV Country Profile

Statistics and Data Analytics


cases in 2018



deaths in 2018

Status of National HPV Vaccination Programme

The HPV vaccine is currently not included in Qatar's national immunization program.


General Information

Human Papillomavirus

Burden of HPV infection

In Qatar, about 2.3% of women in the general population are estimated to have HPV type 16 or 18 at a given time, which causes approximately 72.4% of invasive cervical cancers in the country.1 A 2017 study found that the prevalence of HPV infection amongst Qatari and non-Qatari Arab women were 9.8% and 6.1%, respectively and 7.6% and 16.7% in women with normal and abnormal cytology, respectively. HPV 81 was the most commonly found genotype in women with normal cytology (34.5%), whereas HPV 81, 16 and 59 in women with abnormal cytology (25.0% each).4

Burden of cervical cancer

Cervical cancer, caused by HPV, is the eleventh leading cause of cancer deaths in women in Qatar, causing at least 12 deaths annually among the population of 447,298 women aged 15 years and older who are at risk for the disease.1,2 Between 2012 and 2018, the number of deaths every year due to cervical cancer tripled (4 in 2012 to 12 in 2018), and if decisive action is not taken at the national level, annual deaths due to the disease will triple again by 2040, reaching 38 deaths per year.3 In Qatar, at least 19 women are newly diagnosed with cervical cancer each year.

4 per 100,000 women in Qatar contract cervical cancer annually and 3.2 per 100,000 Qatari women die due to the disease each year. Among countries in the MENA region (as defined by UNAIDS), Qatar’s death and incidence rates due to cervical cancer are about average. For example, Somalia and Morocco have the highest incidence and mortality rates, with 24.0 and 17.2 women per 100,000 being newly diagnosed with cervical cancer annually and at least 21.9 and 12.6 women per 100,000 dying due to cervical cancer per year, respectively. Whereas Iran, Iraq and Yemen have the lowest (around 2 per 100,000 women are diagnosed per year and about 1 per 100,000 die because of cervical cancer annually).2

Cervical cancer incidence and mortality rate projections
Research and Publications
  1. Alemrayat, B., et al. “Cervical Cancer Awareness Campaign in Qatar: A Population-Based Campaign.” Journal of Global Oncology, vol. 4, no. Supplement 2, Sept. 2018, pp. 26s-26s, doi:10.1200/jgo.18.69500.
  2. Elmi, Asha A., et al. “Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar.” PLOS ONE, vol. 12, no. 1, Jan. 2017, p. e0169197, doi:10.1371/journal.pone.0169197.
  3. Alali, Amal, et al. “Knowledge , Attitudes and Practices Regarding Cervical Cancer Screening among Female Health Care Workers in Primary Healthcare in Qatar.” World Family Medicine Journal/Middle East Journal of Family Medicine, vol. 14, no. 8, 2016, pp. 4–15, doi:10.5742/MEWFM.2016.92809.
  4. Bansal, Devendra, et al. “Molecular Epidemiology and Genotype Distribution of Human Papillomavirus (HPV) among Arab Women in the State of Qatar.” Journal of Translational Medicine, vol. 12, no. 1, Nov. 2014, p. 300, doi:10.1186/s12967-014-0300-4.
  5. Al-Meer, F. M., et al. “Knowledge, Attitude and Practices Regarding Cervical Cancer and Screening among Women Visiting Primary Health Care in Qatar.” Eastern Mediterranean Health Journal = La Revue De Sante De La Mediterranee Orientale = Al-Majallah Al-Sihhiyah Li-Sharq Al-Mutawassit, vol. 17, no. 11, Nov. 2011, pp. 855–61.
  6. Al-Thani, Asma AJ, et al. “Prevalence of Human Papillomavirus Infection in Women Attending a Gynecology/Oncology Clinic in Qatar.” Future Virology, vol. 5, no. 4, July 2010, pp. 513–19, doi:10.2217/fvl.10.31.
View all publications
  1. Bruni L, Barrionuevo-Rosas L, Albero G, Serrano B, Mena M, Gómez D, Muñoz J, Bosch FX, de Sanjosé S. ICO/IARC Information Centre on HPV and Cancer (HPV Information Centre). Human Papillomavirus and Related Diseases in Qatar. Summary Report 27 July 2017. [19 October, 2018]

  2. Cancer Today. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.

  3. Cancer Tomorrow. (2018, September). Retrieved October 19, 2018, from https://gco.iarc.fr/.

  4. Elmi AA, Bansal D, Acharya A, Skariah S, Dargham SR, Abu-Raddad LJ, et al. (2017) Human Papillomavirus (HPV) Infection: Molecular Epidemiology, Genotyping, Seroprevalence and Associated Risk Factors among Arab Women in Qatar. PLoS ONE 12(1): e0169197. https://doi.org/10.1371/journal.pone.0169197

Please notify us if you know of other resources, including academic publications, news articles and information that should be added to this page by emailing: hpvmena@gmail.com.